Market closed
Vivos Therapeutics Inc./$VVOS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Ticker
$VVOS
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
109
ISIN
US92859E2072
Website
VVOS Metrics
BasicAdvanced
$15M
-
-$1.71
-
-
Price and volume
Market cap
$15M
52-week high
$3.81
52-week low
$1.98
Average daily volume
88K
Financial strength
Current ratio
0.767
Quick ratio
0.651
Long term debt to equity
21.148
Total debt to equity
31.745
Management effectiveness
Return on assets (TTM)
-61.21%
Return on equity (TTM)
-450.47%
Valuation
Price to revenue (TTM)
1.145
Price to book
3.39
Price to tangible book (TTM)
12.4
Price to free cash flow (TTM)
-1.154
Growth
Revenue change (TTM)
9.47%
Earnings per share change (TTM)
-83.12%
3-year revenue growth (CAGR)
-5.04%
3-year earnings per share growth (CAGR)
-59.28%
VVOS News
AllArticlesVideos
Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript
Seeking Alpha·2 days ago
Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call
GlobeNewsWire·4 days ago
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Vivos Therapeutics Inc. stock?
Vivos Therapeutics Inc. (VVOS) has a market cap of $15M as of May 18, 2025.
What is the P/E ratio for Vivos Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Vivos Therapeutics Inc. (VVOS) stock is 0 as of May 18, 2025.
Does Vivos Therapeutics Inc. stock pay dividends?
No, Vivos Therapeutics Inc. (VVOS) stock does not pay dividends to its shareholders as of May 18, 2025.
When is the next Vivos Therapeutics Inc. dividend payment date?
Vivos Therapeutics Inc. (VVOS) stock does not pay dividends to its shareholders.
What is the beta indicator for Vivos Therapeutics Inc.?
Vivos Therapeutics Inc. (VVOS) does not currently have a Beta indicator.